The 20 Best Bladder Cancer Doctors Near Me in Yonkers, NY

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Guarionex Decastro is a Urologist practicing medicine in New York, New York. Dr. Decastro is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

Matthew Galsky is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Galsky is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Galsky is currently accepting new patients.

Reza Mehrazin is a Urologist practicing medicine in New York, New York. Dr. Mehrazin is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Mehrazin is currently accepting new patients.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Dr. Lerner received his Medical Degree with honors (cum laude) from the State University of New York Health Science Center at Brooklyn, New York. He was elected as a member to the Alpha Omega Alpha, Honor Medical Society. Dr. Lerner is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Lerner is board certified in American Board Of Urology.

David Solit is an Oncologist practicing medicine in New York, New York. Dr. Solit is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, PIK3CA-Related Overgrowth Spectrum, Tissue Biopsy, and Nephrectomy. Dr. Solit is currently accepting new patients.

Thomas Rechtschaffen is a Urologist practicing medicine in Yonkers, New York. Dr. Rechtschaffen is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Interstitial Cystitis, Enlarged Prostate (BPH), UPJ Obstruction, Ureteroscopy, and Prostatectomy. Dr. Rechtschaffen is board certified in American Board Of Urology.

Alexander C. Small, MD, is an Attending Physician and Assistant Professor at Montefiore-Einstein. Dr. Small specializes in the treatment of urological diseases, cancer and kidney stones through the use of minimally invasive, robotic and endoscopic surgery. Dr. Small is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy.

Michael Lipsky is a Urologist practicing medicine in New York, New York. Dr. Lipsky is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His clinical expertise encompasses Prostate Cancer, Urinary Tract Infection (UTI), UPJ Obstruction, Ureteroscopy, and Cystectomy.

Stephen W. Reese, MD, is an attending physician at Montefiore Einstein and Assistant Professor at our Albert Einstein College of Medicine. Dr. Reese cares for patients with urologic cancers, using minimally invasive and open surgical approaches. He has a particular interest in the management of urologic cancers, including kidney, prostate, bladder, adrenal and testicular cancer and works to care for patients in a multidisciplinary setting with his colleagues in medical and radiation oncology. In 2017, Dr. Reese received his Doctor of Medicine at Boston University School of Medicine. He completed his residency training at Brigham and Women’s Hospital in Boston, MA in 2022 and then completed a Society of Urologic Oncology (SUO) Fellowship at Memorial Sloan Kettering Cancer Center in 2024. Dr. Reese is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Venous Thromboembolism (VTE), Prostate Cancer, Nephrectomy, and Cystectomy.

Mark Schoenberg, MD, is a Chair, Urology and Professor, Urology at Montefiore Einstein. As a distinguished leader in the field of urology, Dr. Schoenberg's clinical focus centers on the treatment of bladder cancer. Dr. Schoenberg is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.

Marc Janis is a Urologist practicing medicine in Mount Vernon, New York. Dr. Janis is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

Eric Margolis is a Urologist practicing medicine in Englewood, New Jersey. Dr. Margolis is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Frequent or Urgent Urination, Urinary Incontinence, Ureteroscopy, and Prostatectomy. Dr. Margolis is board certified in American Board Of Urology.

Robert Alter is an Otolaryngologist practicing medicine in Hackensack, New Jersey. Dr. Alter is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Ravi Munver is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Munver is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Horseshoe Kidney, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Munver is board certified in American Board Of Urology.

Michelle Kim is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Bladder Cancer, Muscle Invasive Bladder Cancer, and Ureteroscopy. Dr. Kim is board certified in American Board Of Urology.